,mitoparp,293,293 + high NAD,mitoparp + high NAD,mitoparp + low NAD,293 + low NAD,subsystem
1PPDCRc_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
1PPDCRc_NADPH_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
2HBO,-1000.0,-1000.0,-0.016999999999995453,-0.016999999999995453,-0.01099293286218787,-0.01099293286218787,Threonine and Methionine degradation
2HBt2,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
2OXOADOXm,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan / Lysine Metabolism 
34HPPOR,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
3HBCOAHLm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Valine degradation
3SALATAi,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cysteine degradation I
3SPYRSP,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cysteine degradation I
4ABUTtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,GABA shunt - transport
4aabutn_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
5AOPtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Haem Synthesis
AACTOORm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Glycine degradation
AASAD3m,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
ABTArm,0.0,-1000.0,-1000.0,0.0,0.0,-1000.0,GABA shunt
ABUTD,0.0,0.0,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
ACACT10m,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
ACACT1rm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA and ketone body metabolism / Ketogenesis
ACACt2,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - core
ACACt2mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
ACADLC14_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,FA metabolism
ACADLC16_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,FA metabolism
ACALDtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Alcohol metabolism
ACCOAC,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
ACCOALm,0.0,0.0,0.0,0.0,0.0,0.0,Propanoate metabolism
ACITL,0.0,0.0,0.0,0.0,0.0,0.0,Reductive carboxylation / Acetyl-CoA production for biosynthesis
ACITLm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
ACOAHi,0.0,0.0,0.0,0.0,0.0,0.0,Acetate production
ACOATA,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
ACONT,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Reductive carboxylation
ACONTm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,TCA cycle
ACOT2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
ACSm,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ACt2r,-0.01,-0.01,-0.01,-0.01,-0.01,-0.01,Boundary Conditions - Biomarkers
ADK1,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cytosolic misc
ADK1m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,TCA cycle periphery
ADNK1,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Methionine degradation
ADSL1,0.0,0.0,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
ADSS,0.0,0.0,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
AGMTm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Arginine degradation
AHC,0.0,0.0,0.0,0.0,0.0,0.0,Methionine degradation
AKGDm,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle
AKGMALtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Malate aspartate shuttle
AKGt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
ALASm,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
ALATA_L,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cytosolic misc
ALAt2r,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
ALCD2if,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ALCD2yf,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2x,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2xm,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
AMCOXO,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
AMCOXO2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
AMPD1,0.0,0.0,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
AMPTASECG,0.0,0.0,0.0,0.0,0.0,0.0,Glutathione degradation
AOBUTDsm,0.0,0.0,0.0,0.0,0.0,0.0,Glycine degradation
APAT2rm,0.0,-1000.0,-1000.0,0.0,0.0,-1000.0,Beta-alanine degradation
APRTO2m_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
ARGDCm,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
ARGN,0.0,0.0,0.0,0.0,0.0,0.0,Urea Cycle
ARGNm,0.0,0.0,0.0,0.0,0.0,0.0,Urea Cycle
ARGSL,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Urea Cycle
ARGSS,0.0,0.0,0.0,0.0,0.0,0.0,Urea Cycle
ARGSUCt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
ARGtiDF,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
ARGtmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
ASNS1,0.0,0.0,0.0,0.0,0.0,0.0,Asparagine synthesis
ASNtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
ASP1DC,0.0,0.0,0.0,0.0,0.0,0.0,Beta-alanine synthesis
ASPGLUmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Malate aspartate shuttle
ASPTA,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Malate aspartate shuttle
ASPTAm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Malate aspartate shuttle
ASPte,-0.154,-0.154,-0.154,-0.154,-0.154,-0.154,Boundary conditions - nonessential amino acids
ATPtmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
BALAtmr,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
BDHm,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Ketone bodies - degradation
BHBt,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - core
BHBtmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
BILIRED,0.0,0.0,0.0,0.0,0.0,0.0,Haem Degradation
BILIRED2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Haem Degradation
BUTt2mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
BUTt2r,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - alternative fuels
Biomass_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - core
Biomasst_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
C160CPT1,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Carnitine shuttle
C160CPT2,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Carnitine shuttle
CBPSam,0.0,0.0,0.0,0.0,0.0,0.0,Citrulline biosynthesis
CDSm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cardiolipin synthesis
CHLtmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
CHOLtu,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
CIII_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Electron transport chain
CII_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Electron transport chain
CITtamB,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
CITtbm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
CIV_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Electron transport chain
CI_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Electron transport chain
CK,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Creatine ATP buffer
CKc,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Creatine ATP buffer
CLPN_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cardiolipin synthesis
CLS_hsm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
CO2t,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - core
CO2tm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
COAtmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COAtmC_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COt,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
CPPPGO,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
CREATtmdiffir,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
CSm,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle
CV_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Electron transport chain
CYANt,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
CYANtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
CYSTA,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cysteine degradation II
CYSTAm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cysteine degradation II
CYSTGL,0.0,0.0,0.0,0.0,0.0,0.0,Methionine and Serine degradation
CYSTS,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Methionine and Serine degradation
CYStec,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
CYTK1m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cardiolipin synthesis
DHFR,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
DHPR,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Phenylalanine degradation
ECOAH12m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Valine degradation
ECOAH1m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA metabolism
ECOAH9m,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
ENO,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycolysis/gluconeogenesis
ETOHt,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
FA160ACPH,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
FACOAL160i,0.0,0.0,0.0,0.0,0.0,0.0,Carnitine shuttle
FACOAL40im,0.0,0.0,0.0,0.0,0.0,0.0,Butanoate metabolism
FBA,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycolysis/gluconeogenesis
FBP,0.0,0.0,0.0,0.0,0.0,0.0,Gluconeogenesis
FCLTm,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
FE2t,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
FE2tm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
FKYNH,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
FOLR2,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
FOLt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FORt2mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
FORt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
FTCD,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Folate cytosolic
FTHFDH,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
FTHFDHm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
FTHFL,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
FTHFLm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Folate mitochondrial
FUM,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cytosolic misc
FUMAC,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
FUMm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,TCA cycle
FUMt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
FUMtmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
G3PD1,-1000.0,-1000.0,-4.4329999999999945,-4.432999999999995,-4.3081267605633755,-4.308126760563375,Glycerol phosphate shuttle
G5SADrm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Proline degradation/synthesis
G5SDym,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Proline synthesis
G6PDH2r,0.0,0.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
G6PPer,0.0,0.0,0.0,0.0,0.0,0.0,Gluconeogenesis
GAPD,-1000.0,-1000.0,-0.8204999999999991,0.0,0.0,-0.7773157894736833,Glycolysis/gluconeogenesis
GCCam,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycine cleavage system (GCS)
GCCbim,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycine cleavage system (GCS)
GCCcm,-1000.0,-1000.0,-0.3439999999999967,-0.34400000000000003,-0.18590638297872342,-0.1859063829787216,Glycine cleavage system (GCS)
GHMT2r,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Serine and glycine biosynthesis
GHMT2rm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Serine and glycine biosynthesis
GLCt1r,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - core
GLNS,0.0,0.0,0.0,0.0,0.0,0.0,Glutamine synthesis
GLNtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
GLU5Km,0.0,0.0,0.0,0.0,0.0,0.0,Proline synthesis
GLUCYS,0.0,0.0,0.0,0.0,0.0,0.0,Glutathione synthesis
GLUDC,0.0,0.0,0.0,0.0,0.0,0.0,GABA shunt
GLUDxi,0.0,0.0,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis - cytosolic
GLUDxm,0.0,0.0,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis
GLUDy,0.0,0.0,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis - cytosolic
GLUDym,0.0,0.0,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis
GLUN_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Glutamine degradation - cytosolic
GLUNm,0.0,0.0,0.0,0.0,0.0,0.0,Glutamine degradation
GLUt2mB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
GLUt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
GLYC3Ptm,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GLYCt,-0.01,-0.01,-0.01,-0.01,-0.01,-0.01,Boundary conditions - alternative fuels
GLYCtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
GLYK,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GLYOXm,0.0,0.0,0.0,0.0,0.0,0.0,Glycine degradation
GLYt2r,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
GLYtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
GND,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
GPAMm_hsB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GTHO,0.0,0.0,0.0,0.0,0.0,0.0,ROS defense
GTHOm,0.0,0.0,0.0,0.0,0.0,0.0,ROS defense
GTHP,0.0,0.0,0.0,0.0,0.0,0.0,ROS defense
GTHPm,0.0,0.0,0.0,0.0,0.0,0.0,ROS defense
GTHS,0.0,0.0,0.0,0.0,0.0,0.0,Glutathione synthesis
GluForTx,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Histidine degradation
H2Ot,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
H2Otm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
HACD1m,-1000.0,-1000.0,-1.036,-1.0843043478260916,-1.080500595025143,-1.0323656994369856,FA metabolism
HACD9m,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Isoleucine degradation
HCO3t_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - core
HDCAtm_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - core
HDCAtr,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - core
HEX1,0.0,0.0,0.0,0.0,0.0,0.0,Glycolysis
HGNTOR,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
HIBDm,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Valine degradation
HISD,0.0,0.0,0.0,0.0,0.0,0.0,Histidine degradation
HIStiDF,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
HKYNH,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Tryptophan Metabolism 
HMBS,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
HMGCOASim,0.0,0.0,0.0,0.0,0.0,0.0,Ketogenesis
HMGLm,0.0,0.0,0.0,0.0,0.0,0.0,Ketogenesis / Leucine degradation
HOXG,0.0,0.0,0.0,0.0,0.0,0.0,Haem Degradation
Hct_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
Hmt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
HtmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
ICDHxm,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle
ICDHy,-0.1,-0.1,-0.09999999999999999,-0.09999999999999999,-0.09626373626373627,-0.09626373626373627,Reductive carboxylation
ICDHyrm,-1000.0,-1000.0,-75.05917426191193,-2.2126406643662255,-1.7582325816171887,-59.64433713161324,TCA cycle
ICITt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
ILETAm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Isoleucine degradation
ILEt5m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
ILEtec,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
IZPN,0.0,0.0,0.0,0.0,0.0,0.0,Histidine degradation
KYN3OX,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
LDH_Dm_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycine degradation
LDH_L,-1000.0,-1000.0,-2.0554999999999866,-2.0874999999999946,-1.3498674911660744,-1.3291749116607685,Glycolysis/gluconeogenesis
LEUTAm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Leucine degradation
LEUt5m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
LEUtec,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
LGTHLm_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycine degradation
LPCOXc_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
LYSOXc_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
LYStiDF,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
LYStmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
L_LACt2r,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - core
MACACI,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
MALSO3tm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MALSO4tm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MALTSULtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MAL_Lte,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
MALtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MCCCrm,0.0,0.0,0.0,0.0,0.0,0.0,Leucine degradation
MCLOR,-1000.0,-1000.0,-0.00599999999999678,-0.0059999999999954525,-0.003879858657240875,-0.0038798586572417336,Cysteine degradation II
MCOATA,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA synthesis - cytosolic
MCPST,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
MCPSTm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
MDH,-1000.0,-1000.0,-2.7050000000000005,-2.7050000000000005,-2.510105590062112,-2.510105590062112,Malate aspartate shuttle
MDHm,-1000.0,-1000.0,0.0,0.0,0.0,0.0,TCA cycle
ME1m,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
ME2,0.0,0.0,0.0,0.0,0.0,0.0,Cytosolic misc
ME2m,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
MECR14C_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
MECR16C_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
MERCPLACt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
METAT,0.0,0.0,0.0,0.0,0.0,0.0,Methionine degradation
METAT2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Methionine degradation
METtec,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
MGCHrm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Leucine degradation
MMCDm,0.0,0.0,0.0,0.0,0.0,0.0,Propanoate synthesis
MMEm,-1000.0,0.0,0.0,-1000.0,-1000.0,0.0,Propanoate metabolism
MMMm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Propanoate metabolism
MMSAD1m,0.0,0.0,0.0,0.0,0.0,0.0,Propanoate metabolism
MMSAD3m,0.0,0.0,0.0,0.0,0.0,0.0,Beta-alanine degradation
MMSAD3m2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Beta-alanine degradation
MTHFC,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Folate cytosolic
MTHFCm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Folate mitochondrial
MTHFD,-1000.0,-1000.0,-0.01,-0.01,-0.009000000000000001,-0.009000000000000001,Folate cytosolic
MTHFD2m,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Folate mitochondrial
MTHFDm,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Folate mitochondrial
MTPC14_MitoCore,-1000.0,-1000.0,0.0,0.0,0.0,0.0,FA metabolism
MTPC16_MitoCore,-1000.0,-1000.0,0.0,0.0,0.0,0.0,FA metabolism
NABTNOm,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
NADHt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADHtm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADtm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NDPK1,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Cytosolic misc
NDPK1m,0.0,-1000.0,-1000.0,0.0,0.0,-1000.0,TCA cycle periphery
NDPK3m,0.0,-1000.0,-1000.0,0.0,0.0,-1000.0,Cardiolipin synthesis
NH4t3r,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
NNT_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
NOS1,0.0,0.0,0.0,0.0,0.0,0.0,NOS Signalling
NOS2,0.0,0.0,0.0,0.0,0.0,0.0,NOS Signalling
NOt,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
O2t,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - core
O2tm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
OAAt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
OCBTm,0.0,0.0,0.0,0.0,0.0,0.0,Citrulline biosynthesis
OCOAT1m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Ketone bodies - degradation
OF_ATP_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Objective Function - ATP 
OF_HEME_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Objective Function - Heme
OF_LIPID_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Objective Function - Lipid synthesis 
OF_PROTEIN_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Objective Function - Protein Synthesis
OIVD1m,0.0,0.0,0.0,0.0,0.0,0.0,Leucine degradation
OIVD2m,0.0,0.0,0.0,0.0,0.0,0.0,Valine degradation
OIVD3m,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
ORNDC,0.0,0.0,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
ORNTArm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Ornithine degradation
ORNt3mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
ORNt4mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
P5CRm,0.0,0.0,0.0,0.0,0.0,0.0,Proline synthesis
P5CRxm,0.0,0.0,0.0,0.0,0.0,0.0,Proline synthesis
PCFLOPm,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PCHOLHSTDe,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Lipids
PCHOLPm_hs,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PCLAD,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
PCREATtmdiffirB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
PCm,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
PDHm,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle
PEFLIPm,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PEPCK,0.0,0.0,0.0,0.0,0.0,0.0,Gluconeogenesis
PEPCKm,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
PEt,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Lipids
PFK,0.0,0.0,0.0,0.0,0.0,0.0,Glycolysis
PGCD,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Serine and glycine biosynthesis
PGI,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycolysis/gluconeogenesis
PGK,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycolysis/gluconeogenesis
PGL,0.0,0.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
PGM,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycolysis/gluconeogenesis
PGPPTm,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PGPP_hsm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PHEMEtm,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
PHEtec,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
PIt2mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
PPA,0.0,0.0,0.0,0.0,0.0,0.0,Carnitine shuttle
PPAm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Carnitine shuttle
PPAt,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
PPAtmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
PPCOACm,0.0,0.0,0.0,0.0,0.0,0.0,Propanoate metabolism
PPD2CSPc_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Lysine degradation (L-pipecolate pathway)
PPPGOmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
PROD2mB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Proline degradation
PROt2r,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
PROtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
PSERT,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Serine and glycine biosynthesis
PSFLIPm,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PSP_L,0.0,0.0,0.0,0.0,0.0,0.0,Serine and glycine biosynthesis
PSt3,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Lipids
PTRCAT1m_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
PTRCOX1,0.0,0.0,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
PYK,0.0,0.0,0.0,0.0,0.0,0.0,Glycolysis/gluconeogenesis
PYRt2m,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
R03103_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
RE1254C,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Lysine degradation (L-pipecolate pathway)
RE2649M,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Propanoate synthesis
RPE,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Pentose phosphate pathway
RPI,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Pentose phosphate pathway
SACCD3m,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
SO3t_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
SPODMm,0.0,0.0,0.0,0.0,0.0,0.0,ROS defense
SUCCt2m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
SUCCt3m_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
SUCOAS1m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,TCA cycle
SUCOASm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,TCA cycle
SUMt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
TALA,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Pentose phosphate pathway
TCYNTt,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
TCYNTtmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
THRD_L,0.0,0.0,0.0,0.0,0.0,0.0,Threonine degradation
TKT1,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Pentose phosphate pathway
TKT2,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Pentose phosphate pathway
TPI,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Glycolysis/gluconeogenesis
TRPO2,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
TRPt,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
TRPtm_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
TSULt_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
TYRTA,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Tyrosine degradation
TYRTB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
TYRt,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
UPPDC1,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
URCN,0.0,0.0,0.0,0.0,0.0,0.0,Histidine degradation
UREAt,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
UREAtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
VALTAm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Valine degradation
VALt5m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
VALtec,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
r0060,0.0,0.0,0.0,0.0,0.0,0.0,Serine degradation
r0074,0.0,0.0,0.0,0.0,0.0,0.0,Proline / ornithine degradation
r0081,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,TCA cycle periphery
r0122,0.0,0.0,0.0,0.0,0.0,0.0,Glycolysis
r0127,0.0,0.0,0.0,0.0,0.0,0.0,Asparagine degradation
r0129,0.0,0.0,0.0,0.0,0.0,0.0,Glutathione degradation
r0178,0.0,0.0,0.0,0.0,0.0,0.0,GABA shunt
r0193,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation III
r0205,0.0,0.0,0.0,0.0,0.0,0.0,Glycerol phosphate shuttle
r0226,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Folate mitochondrial
r0287,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA metabolism
r0399,0.0,0.0,0.0,0.0,0.0,0.0,Phenylalanine degradation
r0450,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Lysine degradation (saccharopine pathway)
r0464c_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
r0514,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Folate mitochondrial
r0525,-1000.0,-1000.0,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
r0541,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan / Lysine Metabolism 
r0560,0.0,0.0,0.0,0.0,0.0,0.0,Valine degradation
r0594,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
r0595B_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
r0595m_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
r0603,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
r0633,-1000.0,-1000.0,-16.450628726638282,-9.141912732421059,-2.3811493628631593,-4.284814924147645,Fatty acid elongation in mitochondria
r0634,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA metabolism
r0638,-1000.0,-1000.0,-16.450628726638286,-9.141912732421059,-2.3811493628631593,-4.284814924147646,Fatty acid elongation in mitochondria
r0645,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
r0655,0.0,0.0,0.0,0.0,0.0,0.0,Leucine degradation
r0660,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA metabolism
r0678,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0681,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA synthesis - cytosolic
r0682,-1000.0,-1000.0,0.0,-0.24428571428571424,-0.2374044265593561,0.0,FA synthesis - cytosolic
r0691,-1000.0,-1000.0,0.0,-0.24428571428571422,-0.23740442655935606,0.0,FA synthesis - cytosolic
r0692,-1000.0,-1000.0,0.0,-0.24428571428571424,-0.2374044265593561,0.0,FA synthesis - cytosolic
r0693,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA synthesis - cytosolic
r0694,-1000.0,-1000.0,0.0,-0.24428571428571424,-0.2374044265593561,0.0,FA synthesis - cytosolic
r0695,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA synthesis - cytosolic
r0696,-1000.0,-1000.0,0.0,-0.2442857142857143,-0.23740442655935615,0.0,FA synthesis - cytosolic
r0697,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA synthesis - cytosolic
r0701,-1000.0,-1000.0,0.0,-0.24428571428571427,-0.23740442655935612,0.0,FA synthesis - cytosolic
r0702,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA synthesis - cytosolic
r0712,-1000.0,-1000.0,0.0,-0.24428571428571427,-0.23740442655935612,0.0,FA synthesis - cytosolic
r0713,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0722,-1000.0,-1000.0,0.0,0.0,0.0,0.0,FA metabolism
r0724,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA metabolism
r0726,-1000.0,-1000.0,0.0,0.0,0.0,0.0,FA metabolism
r0728,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA metabolism
r0730,-1000.0,-1000.0,0.0,0.0,0.0,0.0,FA metabolism
r0731,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA metabolism
r0732,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA metabolism
r0733,-1000.0,-1000.0,0.0,0.0,0.0,0.0,FA metabolism
r0734,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA metabolism
r0735,-1000.0,-1000.0,-16.45062872663828,-9.141912732421059,-2.3811493628631593,-4.2848149241476445,Fatty acid elongation in mitochondria
r0760,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0761,-1000.0,-1000.0,0.0,-0.24428571428571424,-0.2374044265593561,0.0,FA synthesis - cytosolic
r0762,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA synthesis - cytosolic
r0763,-1000.0,-1000.0,0.0,-0.24428571428571422,-0.23740442655935606,0.0,FA synthesis - cytosolic
r0764,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0765,-1000.0,-1000.0,0.0,-0.24428571428571424,-0.2374044265593561,0.0,FA synthesis - cytosolic
r0766,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0767,-1000.0,-1000.0,0.0,-0.2442857142857143,-0.23740442655935615,0.0,FA synthesis - cytosolic
r0768,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0769,-1000.0,-1000.0,0.0,-0.2442857142857143,-0.23740442655935615,0.0,FA synthesis - cytosolic
r0770,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,FA synthesis - cytosolic
r0771,-1000.0,-1000.0,0.0,-0.2442857142857143,-0.23740442655935615,0.0,FA synthesis - cytosolic
r0772,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0773,-1000.0,-1000.0,0.0,-0.2442857142857146,-0.23740442655935648,0.0,FA synthesis - cytosolic
r0791,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0817,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r0829,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0830,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0830B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0838B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
r0899,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r0913,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0917,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0917b_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0940,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
r0941,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transport - diffusion / artificial
r0942,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0942b_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0962B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
r1078,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
r1088,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
r1154,0.0,0.0,0.0,0.0,0.0,0.0,Threonine and Methionine degradation
r1155,0.0,0.0,0.0,0.0,0.0,0.0,Threonine degradation
r1423,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Misc
r1427,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r1434,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
r1435,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
r1436,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
r1437,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
r1440,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
r1446,0.0,0.0,0.0,0.0,0.0,0.0,FA metabolism
r1447,0.0,0.0,0.0,0.0,0.0,0.0,FA metabolism
r1448,0.0,0.0,0.0,0.0,0.0,0.0,FA metabolism
r1450,0.0,0.0,0.0,0.0,0.0,0.0,FA metabolism
r1451,0.0,0.0,0.0,0.0,0.0,0.0,FA metabolism
r1455,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - uncharacterised
r1512,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary Conditions - Biomarkers
r2398B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r2402B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r2435,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Carnitine shuttle
r2525,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
r2526,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
r2532,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Boundary conditions - nonessential amino acids
r2534,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
